Notizia.

Long Covid Media EventDate & Time: Jul 30, 2024, 08:00 AM in Pacific Time (US and Canada) / 11:00 AM EasternDescription: On Tuesday, July 30, there will be a special media event to announce a new Long Covid clinical trial...

Read more...

SANTA BARBARA — February, 20th, 2024 — Physicians who treat patients with Autosomal Dominant Polycystic Kidney Disease, or ADPKD, look forward to the results of a new clinical study, Santa Barbara Nutrients announced today. Tokyo’s Juntendo University has begun testing the long-term...

Read more...

University of California professor Dr. Thomas Weimbs, a recognized leader in the Polycystic Kidney Disease (PKD) research field, and Dr. Jacob Torres, Head Researcher of Santa Barbara Nutrients (SBN) discovered that a combination of two natural compounds – Beta-hydroxybutyrate (BHB)...

Read more...

SANTA BARBARA, Calif., October 9, 2023 (Newswire.com) – Santa Barbara Nutrients, Inc. is pleased to announce that our medical food product, KetoCitra®, will be utilized in a pilot clinical trial for patients with long-COVID. The trial will be led by faculty...

Read more...

The KETO-ADPKD study is a landmark in the field of nephrology and nutrition, demonstrating improved kidney function as shown by statistically significant increases in eGFR in people with PKD adopting a ketogenic diet. This research helps to bridge the gap...

Read more...